These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8247096)

  • 41. Novel oral amphotericin B formulation (iCo-010) remains highly effective against murine systemic candidiasis following exposure to tropical temperature.
    Wasan KM; Sivak O; Bartlett K; Wasan EK; Gershkovich P
    Drug Dev Ind Pharm; 2015; 41(9):1425-30. PubMed ID: 25170660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy evaluation of a novel submicron amphotericin B emulsion in murine candidiasis.
    Levy MY; Polacheck I; Barenholz Y; Benita S
    J Med Vet Mycol; 1993; 31(3):207-18. PubMed ID: 8360812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose range evaluation of Mycograb C28Y variant, a human recombinant antibody fragment to heat shock protein 90, in combination with amphotericin B-desoxycholate for treatment of murine systemic candidiasis.
    Louie A; Stein DS; Zack JZ; Liu W; Conde H; Fregeau C; Vanscoy BD; Drusano GL
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3295-304. PubMed ID: 21502626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful treatment of disseminated candidiasis resistant to amphotericin B by liposomal amphotericin B: a case report.
    Gokhale PC; Barapatre RJ; Advani SH; Kshirsagar NA; Pandya SK
    J Cancer Res Clin Oncol; 1993; 119(10):569-71. PubMed ID: 8335676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of alternative dosing regimens of poly-aggregated amphotericin B.
    Espada R; Valdespina S; Molero G; Dea MA; Ballesteros MP; Torrado JJ
    Int J Antimicrob Agents; 2008 Jul; 32(1):55-61. PubMed ID: 18534826
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis.
    Morrison CJ; Stevens DA
    Antimicrob Agents Chemother; 1990 May; 34(5):746-50. PubMed ID: 2193617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice.
    Fong IW; Bannatyne RM; Cheng PC
    Clin Invest Med; 1992 Oct; 15(5):434-9. PubMed ID: 1458716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polysaccharide-coated liposomal amphotericin B for the treatment of murine pulmonary candidiasis.
    Miyazaki T; Kohno S; Sasayama K; Inoue Y; Hara K; Ogasawara M; Sato T; Sunamoto J
    Tohoku J Exp Med; 1992 Nov; 168(3):483-90. PubMed ID: 1304655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae.
    Ibrahim AS; Avanessian V; Spellberg B; Edwards JE
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3343-4. PubMed ID: 14506054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of sterols on the therapeutic efficacy of liposomal amphotericin B in murine candidiasis.
    Lopez-Berestein G; Mehta R; Hopfer R; Mehta K; Hersh EM; Juliano R
    Cancer Drug Deliv; 1983; 1(1):37-42. PubMed ID: 6544116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunomodulator tuftsin augments anti-fungal activity of amphotericin B against experimental murine candidiasis.
    Masood AK; Faisal SM; Haque W; Owais M
    J Drug Target; 2002 May; 10(3):185-92. PubMed ID: 12075819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antifungal activity of amphotericin B-lipid admixtures in experimental systemic candidosis in naive mice.
    Shadkchan Y; Segal E
    J Antimicrob Chemother; 1999 Dec; 44(6):787-90. PubMed ID: 10590279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model.
    Andes D; Stamsted T; Conklin R
    Antimicrob Agents Chemother; 2001 Mar; 45(3):922-6. PubMed ID: 11181381
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of the hematoregulatory peptide SK&F 107647 alone and in combination with amphotericin B against disseminated candidiasis in persistently neutropenic rabbits.
    Lyman CA; Gonzalez C; Schneider M; Lee J; Walsh TJ
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2165-9. PubMed ID: 10471559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In-vivo activity and tolerance of conventional formulation versus fat emulsion formulation of amphotericin B in experimental disseminated candidiasis in neutropenic rabbits.
    Chavanet P; Duong M; Buisson M; Hamel H; Dubois C; Bonnin A; Portier H
    J Antimicrob Chemother; 1997 Mar; 39(3):427-30. PubMed ID: 9096196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia.
    Thaler M; Bacher J; O'Leary T; Pizzo PA
    J Infect Dis; 1988 Jul; 158(1):80-8. PubMed ID: 3392423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
    DiNubile MJ; Hille D; Sable CA; Kartsonis NA
    J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the efficacy of cilofungin, fluconazole and amphotericin B in the treatment of systemic Candida albicans infection in the neutropenic mouse.
    Bannatyne RM; Cheng PC; Fong IW
    Infection; 1992; 20(3):168-70. PubMed ID: 1644494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients.
    Caillot D; Casasnovas O; Solary E; Chavanet P; Bonnotte B; Reny G; Entezam F; Lopez J; Bonnin A; Guy H
    J Antimicrob Chemother; 1993 Jan; 31(1):161-9. PubMed ID: 8444659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates.
    Juster-Reicher A; Flidel-Rimon O; Amitay M; Even-Tov S; Shinwell E; Leibovitz E
    Eur J Clin Microbiol Infect Dis; 2003 Oct; 22(10):603-7. PubMed ID: 13680398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.